(2026). Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist. Alzheimer's & Dementia: Translational Research & Clinical Interventions.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Population Pharmacokinetics of Remlifanserin (ACP‐204), a Serotonin 2A Receptor Inverse Agonist."
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Population Pharmacokinetics of Remlifanserin (ACP‐204), a Serotonin 2A Receptor Inverse Agonist."
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.